---
title: "China Resources Double-Crane Pharmaceutical Registers Blood Cancer Drug"
date: "2025-02-11 10:41:56"
summary: "China Resources Double-Crane Pharmaceutical obtained drug registration from China's drug administrator for mercaptopurine tablets. The drug is indicated for acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast phase of chronic myeloid leukemia, according to a Tuesday filing with the Shanghai bourse. Shares of the pharmaceutical company were down 1%..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

China Resources Double-Crane Pharmaceutical obtained drug registration from China's drug administrator for mercaptopurine tablets.

The drug is indicated for acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast phase of chronic myeloid leukemia, according to a Tuesday filing with the Shanghai bourse.

Shares of the pharmaceutical company were down 1% in recent trade.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250210:G2465952:0/)
